Meanwhile, the shift in PNN-CSPG expression from aggrecan to neurocan and brevican implies that AD may also associate with alterations in the underlying core protein expression distinct from traditional PNN CSPG content. The gene discussed is ACAN; the disease is Alzheimer disease.